Published on 14 Mar 2024 on InvestorPlace via Yahoo Finance
The 3 Most Undervalued Biotech Stocks to Buy in March 2024
Biotech stocks are not for investors with a low-risk tolerance. This sector has stocks that are either considered blue-chip names or pre-revenue lotto tickets. It is also one of the most important sectors that produce treatments and drugs for the betterment of mankind. Investing in biotech stocks can be risky since the clinical results of many of their treatments can be unpredictable. However, choosing the right companies can benefit both your portfolio and millions of patients in dire need of treatment.
Over the past year, the stock market has seen an incredible rally but not all biotech stocks have been included. Targeting these undervalued names is a great way to counter-trade the crowded plays in AI and semiconductors. Finding, these companies can be hard, but we have done the work for you!
These 3 undervalued biotech stocks have been left behind so far but things could begin to turn around as we head into March.